Literature DB >> 18464305

Incidence and prevalence of psoriatic arthritis: a systematic review.

Yannis Alamanos1, Paraskevi V Voulgari, Alexandros A Drosos.   

Abstract

OBJECTIVE: Descriptive epidemiological studies of psoriatic arthritis (PsA) in the general population were very limited until the year 2000. Recently, several incidence and prevalence studies of PsA have been reported, suggesting a considerable variation of the disease frequency among different populations. We present a systematic review of incidence and prevalence studies of PsA published after 1987 until December 2006, in order to evaluate and compare their methodology and to summarize their results, and to investigate the possible geographic variations of occurrence of PsA.
METHODS: We conducted a MedLine search including all articles published on PsA incidence and prevalence in the general adult population until December 2006. From each study identified, we extracted the country, year of publication, type of study, criteria of case identification, and incidence or prevalence rates. Methodological criteria for quality included the type of study (prospective or retrospective for incidence studies and retrospective or cross-sectional for prevalence studies), the type of incidence and prevalence rates (crude or adjusted), the criteria of case definition, and the description of the characteristics of the population studied.
RESULTS: A total of 13 studies were identified from the literature search meeting our inclusion criteria. There is a wide variation of annual incidence of PsA (median 6.4, range 0.1-23.1 cases per 105 inhabitants). One incidence study used European Spondylarthropathy Study Group (ESSG) criteria for case definition, while the other studies were based on a coexistence of psoriasis and arthritis in several ways. Three prevalence studies used ESSG criteria for case identification, while the other studies were based on a coexistence of psoriasis and arthritis in several ways. The prevalence estimates vary from 1 case per 105 population in a Japanese study to 420 cases per 105 population in an Italian study (median 180).
CONCLUSION: The occurrence and epidemiological profile of PsA are likely to present important variations among countries and areas of the world. However, several methodological issues and mainly the absence of validated or consensual criteria for case identification and classification of the disease put important limitations on the interpretation of epidemiological data. The establishment of standardized criteria for the diagnosis and classification of PsA cases is necessary for further, valid investigation of the disease epidemiology.

Entities:  

Mesh:

Year:  2008        PMID: 18464305

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  48 in total

1.  The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors:  Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal:  P T       Date:  2010-12

Review 2.  Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotype?

Authors:  William Tillett; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

3.  Chapter 9: options for summarizing medical test performance in the absence of a "gold standard".

Authors:  Thomas A Trikalinos; Cynthia M Balion
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

Review 4.  The Epidemiology of Psoriatic Arthritis.

Authors:  Alexis Ogdie; Pamela Weiss
Journal:  Rheum Dis Clin North Am       Date:  2015-09-11       Impact factor: 2.670

Review 5.  Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East.

Authors:  Mohamed Bedaiwi; Ibrahim A Al-Homood; Ayman El-Garf; Imad Uthman; Nancy Sunna; Reenad Nassier; Haytham Mohamed; Jamal Al Saleh
Journal:  Rheumatol Int       Date:  2019-05-27       Impact factor: 2.631

6.  Clinical features and types of articular involvement in patients with psoriatic arthritis.

Authors:  Salim Dönmez; Ömer Nuri Pamuk; Mustafa Akker; Recep Ak
Journal:  Clin Rheumatol       Date:  2014-07-29       Impact factor: 2.980

7.  The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.

Authors:  Cynthia S Crowson; Eric L Matteson; Elena Myasoedova; Clement J Michet; Floranne C Ernste; Kenneth J Warrington; John M Davis; Gene G Hunder; Terry M Therneau; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2011-03

Review 8.  [Experiences and results from Rheuma-VOR].

Authors:  A Schwarting; M Dreher; G Assmann; T Witte; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

Review 9.  Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence.

Authors:  Alexis Ogdie; J M Gelfand
Journal:  Curr Rheumatol Rep       Date:  2015-10       Impact factor: 4.592

10.  Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria.

Authors:  Hernán Maldonado Ficco; Gustavo Citera; José Antonio Maldonado Cocco
Journal:  Clin Rheumatol       Date:  2014-05-08       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.